Search

everythinglearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

MRI helps evaluate androgenetic alopecia severity.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Injectable treatments can effectively and safely improve hair growth in adults with androgenetic alopecia.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Oral Apremilast effectively treats alopecia areata in most patients.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Women with PCOS have more severe liver disease.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

New scale reliably assesses male hair loss with female pattern.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

RTA 408 cream protects mice from radiation skin damage.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.